Molecular Evolution of Retroviral Vectors for Enhanced Gene Delivery

用于增强基因传递的逆转录病毒载体的分子进化

• 批准号: 0629202
• 负责人: David Schaffer
• 金额: --
• 依托单位: University of California-Berkeley
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-15 至 2010-08-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0629202&HistoricalAwards=false
• 关键词: Molecular; Evolution; Retroviral; Vectors; Enhanced

0629202SchafferThis proposal is an unsolicited submission. The goal of the research is to apply directed evolution and diversity approaches to address two major problems in gene delivery: (1) targeting delivery to specific cells, in this case CD34+ hematopoietic stem cells, and (2) targeted viral integration into specific loci of the human genome. The results will enhance the efficacy and safety of therapeutic gene delivery as well as yield fundamental insights into mechanisms of viral infection. Directed evolution emulates the process of natural evolution, in which large numbers of diverse variants, or mutants, are generated and screened for desired properties. Since it explores a vast number of possible solutions to a problem, it proves effective even in the absence of the detailed mechanistic knowledge necessary to rationally predict and design variants that can successfully achieve a specific goal. Importantly, the examination of the resulting successful variants can greatly enhance understanding of mechanism and open the possibility of further refinement by rational design.

0629202 schaffer此提案是未经请求的提交。该研究的目标是应用定向进化和多样性方法来解决基因传递中的两个主要问题：(1)靶向传递到特定细胞，在这种情况下是CD34+造血干细胞；(2)靶向病毒整合到人类基因组的特定位点。该结果将提高治疗性基因传递的有效性和安全性，并对病毒感染的机制产生根本性的见解。定向进化模拟了自然进化的过程，在这个过程中，大量不同的变体或突变体被产生并筛选出所需的特性。由于它探索了一个问题的大量可能的解决方案，因此即使在缺乏必要的详细机制知识的情况下，它也证明是有效的，这些知识可以合理地预测和设计能够成功实现特定目标的变体。重要的是，对由此产生的成功变体的检查可以极大地增强对机制的理解，并通过合理设计打开进一步改进的可能性。